Arcus Biosciences Inc (RCUS)
18.88
+0.67
(+3.68%)
USD |
NYSE |
Mar 28, 16:00
18.90
+0.02
(+0.08%)
After-Hours: 20:00
Arcus Biosciences Price: 18.88 for March 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 28, 2024 | 18.30 | 19.11 | 18.18 | 18.88 | 744390.0 |
Mar 27, 2024 | 16.90 | 18.54 | 16.64 | 18.21 | 1.006M |
Mar 26, 2024 | 16.66 | 16.74 | 16.31 | 16.65 | 917496.0 |
Mar 25, 2024 | 16.47 | 16.69 | 16.10 | 16.47 | 578538.0 |
Mar 22, 2024 | 17.15 | 17.22 | 16.37 | 16.43 | 574806.0 |
Mar 21, 2024 | 17.48 | 18.08 | 17.22 | 17.24 | 620114.0 |
Mar 20, 2024 | 17.19 | 17.67 | 17.01 | 17.49 | 485700.0 |
Mar 19, 2024 | 17.16 | 17.66 | 17.03 | 17.30 | 568792.0 |
Mar 18, 2024 | 18.92 | 18.98 | 17.16 | 17.22 | 1.003M |
Mar 15, 2024 | 18.20 | 19.18 | 18.08 | 18.98 | 1.640M |
Mar 14, 2024 | 18.77 | 18.93 | 18.03 | 18.32 | 762965.0 |
Mar 13, 2024 | 18.57 | 19.13 | 18.57 | 19.05 | 747493.0 |
Mar 12, 2024 | 18.95 | 19.01 | 18.27 | 18.64 | 828467.0 |
Mar 11, 2024 | 18.05 | 19.35 | 18.05 | 19.01 | 1.284M |
Mar 08, 2024 | 18.19 | 18.50 | 17.76 | 17.99 | 486417.0 |
Mar 07, 2024 | 19.43 | 19.69 | 17.86 | 17.92 | 596447.0 |
Mar 06, 2024 | 19.00 | 19.44 | 18.64 | 19.36 | 695952.0 |
Mar 05, 2024 | 18.81 | 19.13 | 18.51 | 18.78 | 516396.0 |
Mar 04, 2024 | 19.36 | 19.36 | 18.50 | 19.01 | 538581.0 |
Mar 01, 2024 | 19.20 | 19.60 | 18.95 | 19.10 | 877827.0 |
Feb 29, 2024 | 19.55 | 20.00 | 19.00 | 19.13 | 1.002M |
Feb 28, 2024 | 19.88 | 20.10 | 19.13 | 19.15 | 750236.0 |
Feb 27, 2024 | 19.71 | 20.31 | 19.49 | 20.18 | 982987.0 |
Feb 26, 2024 | 19.50 | 20.17 | 19.28 | 19.66 | 1.015M |
Feb 23, 2024 | 19.51 | 19.68 | 18.80 | 19.53 | 1.284M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.44
Minimum
Aug 23 2019
48.47
Maximum
Nov 23 2021
22.44
Average
21.66
Median
Jun 15 2022
Price Benchmarks
Gilead Sciences Inc | 73.24 |
Merck & Co Inc | 131.95 |
Palatin Technologies Inc | 1.87 |
Petros Pharmaceuticals Inc | 1.48 |
NovaBay Pharmaceuticals Inc | 0.1047 |
Price Related Metrics
PS Ratio | 11.94 |
PEG Ratio | -0.3936 |
Price to Book Value | 3.713 |
Earnings Yield | -21.98% |
Market Cap | 1.716B |
PEGY Ratio | -0.3936 |